Eli Lilly produces a TV commercial highlighting the obstacles to patient recovery and the company's role in developing drugs that "give people a chance at health"

Eli Lilly's weight loss drug, Tirzepatide, shows promising results in fatty liver disease

Eli Lilly's prostate cancer drug fails to prolong the time before tumor progression or death in combination with other drugs>

Roche overall revenue increases due to the performance of their eye disease drug, Vabysmo

J&J's autoimmune drug has shown success in a phase 3 trial

Pfizer is launching a new program that aims to improve access to cancer screening and clinical trials in underserved communities

Early trials of Amgen's obesity drug show promising results in reducing weight and maintaining weight loss